These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26745079)

  • 21. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ABO blood type compatibility is not a risk factor for gestational trophoblastic neoplasia development from androgenetic complete hydatidiform moles.
    Sato A; Usui H; Shozu M
    Am J Reprod Immunol; 2020 Jun; 83(6):e13237. PubMed ID: 32191360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTEN and MDM2 expression in the prediction of postmolar gestational trophoblastic neoplasia.
    Lertkhachonsuk R; Tantbirojn P; Paiwattananupant K
    J Reprod Med; 2012; 57(7-8):333-40. PubMed ID: 22838251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gestational trophoblastic diseases in Turkey.
    Ozalp SS; Oge T
    J Reprod Med; 2013; 58(1-2):67-71. PubMed ID: 23447922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinico-pathological study of complete and partial hydatidiform moles in a Nigerian population.
    Osamor JO; Oluwasola AO; Adewole IF
    J Obstet Gynaecol; 2002 Jul; 22(4):423-5. PubMed ID: 12521470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The incidence of gestational trophoblastic disease in Italy: a multicenter survey.
    Salerno A
    J Reprod Med; 2012; 57(5-6):204-6. PubMed ID: 22696813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Presentation of Complete Hydatidiform Mole and Partial Hydatidiform Mole at a Regional Trophoblastic Disease Center in the United States Over the Past 2 Decades.
    Sun SY; Melamed A; Joseph NT; Gockley AA; Goldstein DP; Bernstein MR; Horowitz NS; Berkowitz RS
    Int J Gynecol Cancer; 2016 Feb; 26(2):367-70. PubMed ID: 26588240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of gestational trophoblastic diseases.
    Steigrad SJ
    Best Pract Res Clin Obstet Gynaecol; 2003 Dec; 17(6):837-47. PubMed ID: 14614884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a routine second curettage for hydatidiform mole: a cohort study.
    Yamamoto E; Nishino K; Niimi K; Watanabe E; Oda Y; Ino K; Kikkawa F
    Int J Clin Oncol; 2020 Jun; 25(6):1178-1186. PubMed ID: 32144509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LINE-1 Methylation Patterns as a Predictor of Postmolar Gestational Trophoblastic Neoplasia.
    Lertkhachonsuk R; Paiwattananupant K; Tantbirojn P; Rattanatanyong P; Mutirangura A
    Biomed Res Int; 2015; 2015():421747. PubMed ID: 26448937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P57
    Awosusi BL; Ajani MA; Adegoke OO; Salami AA; Okolo CA
    Niger Postgrad Med J; 2020; 27(4):331-335. PubMed ID: 33154286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical significance of centralized surveillance of hydatidiform mole].
    Jiao LZ; Wang YP; Jiang JY; Zhang WQ; Wang XY; Zhu CG; Zhang YW
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):390-395. PubMed ID: 29961281
    [No Abstract]   [Full Text] [Related]  

  • 34. Hydatidiform mole in Nottingham: a 12-year retrospective epidemiological and morphological study.
    Womack C; Elston CW
    Placenta; 1985; 6(2):93-105. PubMed ID: 4022949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia.
    Braga A; Maestá I; Rocha Soares R; Elias KM; Custódio Domingues MA; Barbisan LF; Berkowitz RS
    Am J Obstet Gynecol; 2016 Sep; 215(3):336.e1-336.e12. PubMed ID: 27094961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gestational trophoblastic syndrome: an audit of 112 patients. A South African experience.
    Moodley M; Tunkyi K; Moodley J
    Int J Gynecol Cancer; 2003; 13(2):234-9. PubMed ID: 12657130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gestational trophoblastic disease in the western region of Saudi Arabia (single-institute experience).
    Anfinan N; Sait K; Sait H
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():8-11. PubMed ID: 24972119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 10-Year Clinical Experience of Gestational Trophoblastic Disease at Rajavithi Hospital, 2001-2010.
    Yanaranop M; Potikul C; Tuipae S
    J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S17-27. PubMed ID: 27266212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Qualitative and quantitative analysis of diffusion-weighted imaging of gestational trophoblastic disease: Can it predict progression of molar pregnancy to persistent form of disease?
    Sefidbakht S; Hosseini F; Bijan B; Hamedi B; Azizi T
    Eur J Radiol; 2017 Mar; 88():71-76. PubMed ID: 28189211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-dose actinomycin D: Efficacy in the prophylaxis of postmolar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole.
    Uberti EM; Diestel MC; Guimarães FE; De Nápoli G; Schmid H
    Gynecol Oncol; 2006 Aug; 102(2):325-32. PubMed ID: 16476471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.